Procter & Gamble Health Limited (NSE:PGHL)
5,699.50
0.00 (0.00%)
Nov 11, 2026, 1:21 PM IST
Procter & Gamble Health Revenue
Procter & Gamble Health had revenue of 3.82B INR in the quarter ending September 30, 2026, with 17.72% growth. This brings the company's total for the last twelve months to 14.91B, up 16.05% year-over-year. In the fiscal year ending March 31, 2026, Procter & Gamble Health had annual revenue of 14.08B with 15.59% growth.
Revenue (ttm)
14.91B
Revenue Growth
+16.05%
P/S Ratio
6.34
Revenue / Employee
11.68M
Employees
1,276
Market Cap
94.48B
Revenue by Geography
- India 10.59B 92.0%
- outside India 925.30M 8.0%
Fiscal year ended Jun 30, 2024 See the full Procter & Gamble Health breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 14.08B | 1.90B | 15.59% |
| Mar 31, 2025 | 12.18B | 667.90M | 5.80% |
| Jun 30, 2024 | 11.51B | -783.60M | -6.37% |
| Jun 30, 2023 | 12.30B | 1.15B | 10.34% |
| Jun 30, 2022 | 11.14B | 1.06B | 10.48% |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 52.13B |
| Akums Drugs and Pharmaceuticals | 48.29B |
| NATCO Pharma | 34.85B |
| Eris Lifesciences | 33.12B |
| Alivus Life Sciences | 26.84B |
| Cohance Lifesciences | 20.57B |
| Aarti Pharmalabs | 19.69B |
| Sun Pharma Advanced Research Company | 19.32B |
Procter & Gamble Health News
- 1 year ago - P&G Health appoints Shashank Srowthy as Executive Director and CFO, effective October 1 - Business Upturn
- 1 year ago - P&G Health shares surge 8% as Q1 revenue jumps 19.5% YoY to Rs 339 crore - Business Upturn
- 2 years ago - P&G Health Q2 FY25: Revenue rises 2.8% YoY to Rs 313.41 crore, net profit surges 25.6% to Rs 82.33 crore - Business Upturn
- 2 years ago - Procter & Gamble Health Q2 FY25 results: Stock jumps 2% ahead of result announcement - Business Upturn